1.29
-0.0542(-4.03%)
Currency In USD
| Previous Close | 1.34 |
| Open | 1.35 |
| Day High | 1.37 |
| Day Low | 1.29 |
| 52-Week High | 2.55 |
| 52-Week Low | 1.13 |
| Volume | 65,179 |
| Average Volume | 43,469 |
| Market Cap | 63.27M |
| PE | -5.16 |
| EPS | -0.25 |
| Moving Average 50 Days | 1.31 |
| Moving Average 200 Days | 1.6 |
| Change | -0.05 |
If you invested $1000 in MediciNova, Inc. (MNOV) 10 years ago, it would be worth $409.52 as of September 07, 2025 at a share price of $1.29. Whereas If you bought $1000 worth of MediciNova, Inc. (MNOV) shares 5 years ago, it would be worth $250 as of September 07, 2025 at a share price of $1.29.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 03, 2025 11:00 AM GMT
LA JOLLA, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces t
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
GlobeNewswire Inc.
Aug 26, 2025 11:00 PM GMT
LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that it successfu
MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million
GlobeNewswire Inc.
Jul 31, 2025 11:30 PM GMT
LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces a